Cargando…

Long noncoding RNA NEAT1 promotes ferroptosis by modulating the miR-362-3p/MIOX axis as a ceRNA

Ferroptosis, a novel form of regulated cell death induced by iron-dependent lipid peroxidation, plays an essential role in the development and drug resistance of tumors. Long noncoding RNA (lncRNA) nuclear paraspeckle assembly transcript 1 (NEAT1) has been reported to be involved in the regulation o...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ying, Luo, Meiying, Cui, Xiaohong, O’Connell, Douglas, Yang, Yongfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433379/
https://www.ncbi.nlm.nih.gov/pubmed/35338333
http://dx.doi.org/10.1038/s41418-022-00970-9
_version_ 1784780621711671296
author Zhang, Ying
Luo, Meiying
Cui, Xiaohong
O’Connell, Douglas
Yang, Yongfei
author_facet Zhang, Ying
Luo, Meiying
Cui, Xiaohong
O’Connell, Douglas
Yang, Yongfei
author_sort Zhang, Ying
collection PubMed
description Ferroptosis, a novel form of regulated cell death induced by iron-dependent lipid peroxidation, plays an essential role in the development and drug resistance of tumors. Long noncoding RNA (lncRNA) nuclear paraspeckle assembly transcript 1 (NEAT1) has been reported to be involved in the regulation of cell cycle, proliferation, apoptosis, and migration of tumor cells. However, the function and molecular mechanism of NEAT1 in regulating ferroptosis in tumors remain unclear. Here, we found that ferroptosis inducers erastin and RSL3 increased NEAT1 expression by promoting the binding of p53 to the NEAT1 promoter. Induced NEAT1 promoted the expression of MIOX by competitively binding to miR-362-3p. MIOX increased ROS production and decreased the intracellular levels of NADPH and GSH, resulting in enhanced erastin- and RSL3-induced ferroptosis. Importantly, overexpression of NEAT1 increased the anti-tumor activity of erastin and RSL3 by enhancing ferroptosis both in vitro and in vivo. Collectively, these data suggest that NEAT1 plays a novel and indispensable role in ferroptosis by regulating miR-362-3p and MIOX. Considering the clinical findings that HCC patients are insensitive to chemotherapy and immunotherapy, ferroptosis induction may be a promising therapeutic strategy for HCC patients with high NEAT1 expression.
format Online
Article
Text
id pubmed-9433379
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-94333792022-09-02 Long noncoding RNA NEAT1 promotes ferroptosis by modulating the miR-362-3p/MIOX axis as a ceRNA Zhang, Ying Luo, Meiying Cui, Xiaohong O’Connell, Douglas Yang, Yongfei Cell Death Differ Article Ferroptosis, a novel form of regulated cell death induced by iron-dependent lipid peroxidation, plays an essential role in the development and drug resistance of tumors. Long noncoding RNA (lncRNA) nuclear paraspeckle assembly transcript 1 (NEAT1) has been reported to be involved in the regulation of cell cycle, proliferation, apoptosis, and migration of tumor cells. However, the function and molecular mechanism of NEAT1 in regulating ferroptosis in tumors remain unclear. Here, we found that ferroptosis inducers erastin and RSL3 increased NEAT1 expression by promoting the binding of p53 to the NEAT1 promoter. Induced NEAT1 promoted the expression of MIOX by competitively binding to miR-362-3p. MIOX increased ROS production and decreased the intracellular levels of NADPH and GSH, resulting in enhanced erastin- and RSL3-induced ferroptosis. Importantly, overexpression of NEAT1 increased the anti-tumor activity of erastin and RSL3 by enhancing ferroptosis both in vitro and in vivo. Collectively, these data suggest that NEAT1 plays a novel and indispensable role in ferroptosis by regulating miR-362-3p and MIOX. Considering the clinical findings that HCC patients are insensitive to chemotherapy and immunotherapy, ferroptosis induction may be a promising therapeutic strategy for HCC patients with high NEAT1 expression. Nature Publishing Group UK 2022-03-25 2022-09 /pmc/articles/PMC9433379/ /pubmed/35338333 http://dx.doi.org/10.1038/s41418-022-00970-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Zhang, Ying
Luo, Meiying
Cui, Xiaohong
O’Connell, Douglas
Yang, Yongfei
Long noncoding RNA NEAT1 promotes ferroptosis by modulating the miR-362-3p/MIOX axis as a ceRNA
title Long noncoding RNA NEAT1 promotes ferroptosis by modulating the miR-362-3p/MIOX axis as a ceRNA
title_full Long noncoding RNA NEAT1 promotes ferroptosis by modulating the miR-362-3p/MIOX axis as a ceRNA
title_fullStr Long noncoding RNA NEAT1 promotes ferroptosis by modulating the miR-362-3p/MIOX axis as a ceRNA
title_full_unstemmed Long noncoding RNA NEAT1 promotes ferroptosis by modulating the miR-362-3p/MIOX axis as a ceRNA
title_short Long noncoding RNA NEAT1 promotes ferroptosis by modulating the miR-362-3p/MIOX axis as a ceRNA
title_sort long noncoding rna neat1 promotes ferroptosis by modulating the mir-362-3p/miox axis as a cerna
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433379/
https://www.ncbi.nlm.nih.gov/pubmed/35338333
http://dx.doi.org/10.1038/s41418-022-00970-9
work_keys_str_mv AT zhangying longnoncodingrnaneat1promotesferroptosisbymodulatingthemir3623pmioxaxisasacerna
AT luomeiying longnoncodingrnaneat1promotesferroptosisbymodulatingthemir3623pmioxaxisasacerna
AT cuixiaohong longnoncodingrnaneat1promotesferroptosisbymodulatingthemir3623pmioxaxisasacerna
AT oconnelldouglas longnoncodingrnaneat1promotesferroptosisbymodulatingthemir3623pmioxaxisasacerna
AT yangyongfei longnoncodingrnaneat1promotesferroptosisbymodulatingthemir3623pmioxaxisasacerna